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Abstract 
The aim of this analysis was to examine mean differences in the speed of recovery (days) from COVID-19 
infection by case-patients among age groups in Mpumalanga province. A sample of 5723 case-patients 
distributed among ten distinct age groups, beginning from 0-9 years. Using the date at which the result 
confirming positivity for each case was received and the date at which discharge occurred, the DATEDIF() 
function in Microsoft Excel was used to calculate the speed of recovery, measured by number of days. Time 
from infection to recovery was therefore measured as the number of days from first positive to first negative 
SARSCoV-2 PCR test result. Data was processed in both Excel and Statistical Package for Social Sciences 
(SPSS) prior to conducting statistical data analysis. The mean differences in the speed of recovery among age 
groups were analysed using the mean comparison Analysis of Variance (ANOVA) method. Age groups 0-9 
years and 40-49 years had the longest average recovery speed of 17.32 ±8.84 days and 17.22 ±7.88 days; 
respectively, while the age group 70-79 years had the fastest average recovery speed of 15.43 ±4.51 days. 
ANOVA results show no statistical evidence that the mean recovery speed (days) from differed significantly 
among age groups (F (8, 5714) statistic (= 0.932; p > 0.05) at 5% significance level.  
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1. Introduction  
Human coronaviruses have become common throughout the globe. Numerous different coronaviruses are 
identified in animals, while merely a small number of them can cause disease in human beings (Department of 
Health, 2020). The coronavirus disease 2019 (COVID-19) was first reported in December 2019 by the World 
Health Organization (WHO) country office following a cluster of pneumonia cases in Wuhan City, Hubei 
province, China (National Institute of Communicable Diseases, 2020). SARS-CoV-2 was confirmed as the 
causative virus of COVID-19, which has rapidly become a global pandemic continuing to spread across 
countries in the world. Most of the case-patients initially identified were dealers and vendors at a seafood, 
poultry and live wildlife market in China (WHO, 2020). According to the Department of Health (2020), people 
who are most at higher risk are the elderly, healthcare workers and those with co-morbidities.  
 
The spread of the disease is believed to happen primarily via respiratory droplets produced when an infected 
person coughs or sneezes, similar to how influenza and other respiratory pathogens spread. The majority of cases 
have occurred in people with close physical contact to cases and healthcare workers proving health care services 
to patients with COVID-19 (National Institute of Communicable Diseases, 2020). COVID-19 basically affects 
all ages, and impacts other health conditions. Until the vaccine is found, the pandemic will remain as a serious 
global health threat. Since COVID-19 is a new disease, there is limited information regarding risk factors for 
severe diseases. In some cases, people who get COVID-19 can become seriously ill and develop difficulties in 
breathing, while severe complications can lead to death. The older population (50+ years) as well as those with 
underlying medical conditions like those who are immune-compromised like serious heart problems and chronic 
lung disease is more likely to develop serious illnesses.  
 
Since outbreak, the pandemic has shown a low proportion of cases among young children (National Institute of 
Communicable Diseases, 2020). Age disparities in the observed cases are believed to be explained by children 
having lower susceptibility to infection, lower propensity to show clinical symptoms. The Center for Disease 
Control (2020) states that COVID-19 is a new disease and there is limited information regarding risk factors for 
severe disease. Based on currently available information and clinical expertise, older adults and people with 
underlying medical conditions have been observed to be at higher risk for severe illnesses from COVID-19. In 
terms of recovery rates, scientists and researchers globally are constantly tracking infections and recoveries. The 
data at disposal is only on confirmed cases and does not include people who do get COVID-19 tests. In addition, 
available data does not contain information about the outcome of every infection. Treatment is mainly supportive 
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in form provision of oxygen for patients with shortness of breath, and other symptoms likes fever, dry cough and 
sore throat.  
1.1. Research Objective  
 To determine mean differences in the speed of recovery (days) from COVID-19 infection by case-
patients among age groups in Mpumalanga province.   
 
1.2. Research Question  
 Are there mean differences in the speed of recovery (days) from COVID-19 infection by case-patients 
among age groups in Mpumalanga province?   
 
1.3. Research Hypothesis   
 There are mean differences in the speed of recovery (days) from COVID-19 infection by case-patients 
among age groups in Mpumalanga province.  
 
1.4. Significance of the Study  
The results from this analysis are expected to contribute greatly towards developing mechanisms that can be 
deemed relevant to help curtail the spread of the disease among age groups in the province. In terms of 
monitoring the disease spread, findings are expected to provide insights on age groups where mapping and 
tracking would need to be continuously conducted using relevant intelligence mechanisms and approaches    
 
2. Methodology   
 
2.1. Design 
A descriptive research design was used in this research study. The categorical factor was age group, while and 
dependent variable was the recovery speed measured using the number of days taken to full recovery.  
 
2.2. Population and Sample 
The population for the study was patients who got infected and first tested positive from the first SARS CoV-2 
PCR test and later tested negative to SARS-CoV-2 PCR test after a certain period. The sample consists of 5 723 
clinically confirmed recovered cases as at 21 July 2020.        
 
2.3. Data 
The secondary dataset used in the analysis was obtained from Mpumalanga Department of Health (MDoH). Data 
cleaning and processing was initially conducted in Excel and Statistical Package for Social Sciences (SPSS) 
prior to conducting statistical data analysis. The variable “recovery speed (days)” was calculated by inserting the 
date at which the result confirming positivity was received and the date discharge occurred into the DATEDIF() 
function in Excel. Thus, time from infection to recovery is measured as the number of days from first positive to 
first negative SARSCoV-2 PCR test result.  
 
2.4. Treatment  
The sample was categorised into nine distinct 10-year interval age groups, beginning from 0-9 years.  
 
2.5. Statistical Analysis Technique 
The univariate one-way Analysis of Variance (ANOVA) statistical technique was applied to examine mean 
differences in the recovery speed (days) from COVID-19 infection; based on the following function. 
    hw,vF ijij                    (1) 
 
where F represents the function which transforms w into v; with v denoting recovery speed (days) of the ith case 
in district j; w represents the ith positivity and discharge record applied to age group j; and h denotes a positive 
scalar, which overall further reduces to:    
 
ikijjjij εGRS  ;         (2) 
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where RS is the recovery speed (days) of the ith case in district j; G represents the age group on the ith case in age 
group j; and j  
denotes the average speed of recovery attributed to a specific age group. Descriptive statistics 
were computed to analyse the means, standard deviation and standard error estimates; while the ANOVA Tukey 
HSD post hoc test was used to examine whether any significant differences existed between the patients’ mean 
recovery speeds for each age group at 5 percent level of significance.  
 
3. Results and Analysis  
 
3.1. Frequencies  
 
Table 1: Frequencies  
Age group Frequency Percent Cumulative Percent 
0-9 years 192 3.4 3.4 
10-19 years 321 5.6 9 
20-29 years 925 16.2 25.1 
30-39 years 1831 32.0 57.1 
40-49 years 1208 21.1 78.2 
50-59 years 829 14.5 92.7 
60-69 years 306 5.3 98.1 
70-79 years 69 1.2 99.3 
>= 80 years 42 0.7 100 
Total 5723 100   
 
Table 1 presents frequencies of case-patients per each age group. Results show that the age group 30-39 years 
accounted for the largest proportion of 32% (n = 1831), followed by the age group 40-49 years which accounted 
for 21% (n = 1208) of the cases. The age group with the third highest proportion is the 20-29 years with 16% (n 
= 925) cases, while the age group with the fourth highest proportion is 50-59 years which accounted for 
approximately 15% (n = 829) of the cases.     
 
3.2. Descriptive Statistics  
Table 2: Descriptive statistics 
Age group N Mean (Std Dev) 
95% Confidence Interval for Mean 
Lower Bound Upper Bound 
0-9 years 192 17.32 ±8.84 16.06 18.58 
10-19 years 321 16.55 ±6.71 15.81 17.29 
20-29 years 925 16.69 ±6.97 16.24 17.14 
30-39 years 1831 16.79 ±7.15 16.46 17.12 
40-49 years 1208 17.22 ±7.88 16.77 17.67 
50-59 years 829 16.92 ±7.34 16.42 17.42 
60-69 years 306 16.86 ±7.65 16.00 17.72 
70-79 years 69 15.43 ±4.51 14.35 16.52 
>= 80 years 42 16.93 ±6.89 14.78 19.07 
Total 5723 16.88 ±7.53 16.69 17.07 
Table 2 presents descriptive statistics for the speed (days) at which patient cases recovered from the disease 
across age groups in Mpumalanga province. From the entire sample of five thousand seven hundred and twenty-
three (n = 5 723) COVID-19 infected cases, the age groups 0-9 years and 40-49 years had the longest average 
recovery speed of 17.32 ±8.84 days and 17.22 ±7.88 days; respectively. The age group 70-79 years had the 
fastest average recovery speed of 15.43 ±4.51 days.    
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3.3. ANOVA Statistics 
 
Table 3: Test of homogeneity of variances  
Recovery speed (days) 
Levene Statistic df1 df2 Sig. 
2.551 8 5714 .009 
 
The Levene statistics (F-statistic = 2.551; p < 0.05), which tests for the assumption of homogeneity of variance 
show evidence of existence of significant differences in the variances of age groups. Therefore, the assumption 
of homogeneity of variance was not satisfied.  
Table 4: ANOVA  
Recovery speed (days) 
 Sum of Squares df Mean Square F Sig. 
Between Groups 403.335 8 50.417 .932 .488 
Within Groups 308937.801 5714 54.067   
Total 309341.136 5722    
 
Table 4 ANOVA results show no statistical evidence that the mean recovery speed (days) from COVID-19 
infection differed significantly among age groups (F (8, 5714) statistic (= 0.932; p > 0.05) at 5% level of 
significance. To validate that there were no significant differences in average recovery speeds in case patients 
among all age groups, the Turkey HSD post hoc test were conducted, with results presented below.  
 
Table 5: Multiple comparisons  
Dependent Variable:   Recovery speed (days)   
Tukey HSD   
(I) Age group (J) Age group Mean 
Difference (I-J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0-9 years 
10-19 years .769 .671 .967 -1.31 2.85 
20-29 years .624 .583 .978 -1.19 2.43 
30-39 years .525 .558 .991 -1.21 2.26 
40-49 years .098 .571 1.000 -1.68 1.87 
50-59 years .399 .589 .999 -1.43 2.23 
60-69 years .458 .677 .999 -1.64 2.56 
70-79 years 1.883 1.032 .666 -1.32 5.09 
>= 80 years .389 1.253 1.000 -3.50 4.28 
10-19 years 
0-9 years -.769 .671 .967 -2.85 1.31 
20-29 years -.146 .476 1.000 -1.62 1.33 
30-39 years -.245 .445 1.000 -1.63 1.14 
40-49 years -.672 .462 .876 -2.10 .76 
50-59 years -.371 .483 .998 -1.87 1.13 
60-69 years -.311 .587 1.000 -2.13 1.51 
70-79 years 1.114 .976 .968 -1.91 4.14 
>= 80 years -.380 1.207 1.000 -4.12 3.36 
20-29 years 
0-9 years -.624 .583 .978 -2.43 1.19 
10-19 years .146 .476 1.000 -1.33 1.62 
30-39 years -.099 .297 1.000 -1.02 .82 
40-49 years -.526 .321 .784 -1.52 .47 
50-59 years -.225 .352 .999 -1.32 .87 
60-69 years -.165 .485 1.000 -1.67 1.34 
70-79 years 1.259 .918 .908 -1.59 4.11 
>= 80 years -.235 1.160 1.000 -3.83 3.37 
30-39 years 
0-9 years -.525 .558 .991 -2.26 1.21 
10-19 years .245 .445 1.000 -1.14 1.63 
20-29 years .099 .297 1.000 -.82 1.02 
40-49 years -.427 .273 .823 -1.27 .42 
50-59 years -.126 .308 1.000 -1.08 .83 
60-69 years -.066 .454 1.000 -1.48 1.34 
Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 




70-79 years 1.358 .902 .853 -1.44 4.16 
>= 80 years -.136 1.148 1.000 -3.70 3.43 
40-49 years 
0-9 years -.098 .571 1.000 -1.87 1.68 
10-19 years .672 .462 .876 -.76 2.10 
20-29 years .526 .321 .784 -.47 1.52 
30-39 years .427 .273 .823 -.42 1.27 
50-59 years .301 .332 .993 -.73 1.33 
60-69 years .361 .471 .998 -1.10 1.82 
70-79 years 1.785 .910 .570 -1.04 4.61 
>= 80 years .292 1.154 1.000 -3.29 3.87 
50-59 years 
0-9 years -.399 .589 .999 -2.23 1.43 
10-19 years .371 .483 .998 -1.13 1.87 
20-29 years .225 .352 .999 -.87 1.32 
30-39 years .126 .308 1.000 -.83 1.08 
40-49 years -.301 .332 .993 -1.33 .73 
60-69 years .060 .492 1.000 -1.47 1.59 
70-79 years 1.484 .921 .799 -1.37 4.34 
>= 80 years -.009 1.163 1.000 -3.62 3.60 
60-69 years 
0-9 years -.458 .677 .999 -2.56 1.64 
10-19 years .311 .587 1.000 -1.51 2.13 
20-29 years .165 .485 1.000 -1.34 1.67 
30-39 years .066 .454 1.000 -1.34 1.48 
40-49 years -.361 .471 .998 -1.82 1.10 
50-59 years -.060 .492 1.000 -1.59 1.47 
70-79 years 1.425 .980 .877 -1.62 4.47 
>= 80 years -.069 1.210 1.000 -3.82 3.69 
70-79 years 
0-9 years -1.883 1.032 .666 -5.09 1.32 
10-19 years -1.114 .976 .968 -4.14 1.91 
20-29 years -1.259 .918 .908 -4.11 1.59 
30-39 years -1.358 .902 .853 -4.16 1.44 
40-49 years -1.785 .910 .570 -4.61 1.04 
50-59 years -1.484 .921 .799 -4.34 1.37 
60-69 years -1.425 .980 .877 -4.47 1.62 
>= 80 years -1.494 1.439 .982 -5.96 2.97 
>= 80 years 
0-9 years -.389 1.253 1.000 -4.28 3.50 
10-19 years .380 1.207 1.000 -3.36 4.12 
20-29 years .235 1.160 1.000 -3.37 3.83 
30-39 years .136 1.148 1.000 -3.43 3.70 
40-49 years -.292 1.154 1.000 -3.87 3.29 
50-59 years .009 1.163 1.000 -3.60 3.62 
60-69 years .069 1.210 1.000 -3.69 3.82 
70-79 years 1.494 1.439 .982 -2.97 5.96 
 
The Tukey post hoc tests results show that the mean recovery speed of case-patients in each age group did not 
differ significantly from average recovery speeds of case-patients in other age groups. Therefore, no significant 
differences existed in mean recovery speeds among case-patients across all age groups.  
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Table 6: Homogeneous subsets 
Recovery speed (days) 
Tukey HSDa,b   
Age group N 
Subset for alpha = 0.05 
1 
70-79 years 69 15.43 
10-19 years 321 16.55 
20-29 years 925 16.69 
30-39 years 1831 16.79 
60-69 years 306 16.86 
50-59 years 829 16.92 
>= 80 years 42 16.93 
40-49 years 1208 17.22 
0-9 years 192 17.32 
Sig.  .314 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 168.051. 
b. The group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
Homogenous subsets are an alternate approach regarded to be more suitable for computing and displaying the 
post hoc tests largely when group sizes are quite different. The null hypothesis of the subsets establishes that 
groups computed in the same subset are not significantly different. Results presented in Table 6 indicate no 
evidence of significant differences in average speed of recovery by case patients among all age groups. 
 
4. Conclusion Remarks  
This research study found no evidence of statistically significant differences in the average recovery speed (days) 
from COVID-19 infection case patients across all age groups. The findings imply that provision of clinical and 
health-related interventions aimed at curbing the spread of the COVID-19 disease should not be differentiated 
based on age group since the average recovery speeds among case-patients across all age groups are not 
statistically significantly different.  
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